Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Upadacitinib improved multiple immune-related conditions in one patient.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

JAK inhibitors show promise for treating Alopecia Areata, while statins are not recommended.

34% of patients on hepatitis C treatment had reversible skin issues.

JAK inhibitors show promise in treating difficult skin diseases.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Tofacitinib may help regrow hair in alopecia areata patients.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Tofacitinib treatment for hair loss may worsen acne.

New compounds may soon be tested to treat excessive hair growth in women.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

The diphosphonate was the most effective at preventing calcification in rats.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Blocking 11β-HSD1 reduces stress hormone damage in hair growth cells.

Spironolactone works well for acne and hirsutism, isotretinoin is very effective for acne and may have antiandrogenic effects, and 5 alpha-reductase inhibitors should be considered antiandrogens.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

HDAC6 helps keep ovarian follicles dormant, extending female fertility.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

Cyproterone acetate effectively treats hirsutism and related conditions.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.